Search alternatives:
significant cause » significant change (Expand Search), significant changes (Expand Search), significant gap (Expand Search)
cause decrease » caused decreased (Expand Search), use decreased (Expand Search), causes increased (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
significant cause » significant change (Expand Search), significant changes (Expand Search), significant gap (Expand Search)
cause decrease » caused decreased (Expand Search), use decreased (Expand Search), causes increased (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
-
1
-
2
-
3
The table shows the significant and non-significant altered group with different parameters.
Published 2025Subjects: -
4
-
5
Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers.
Published 2024“…<p>(<b>A)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on days 1–22. (<b>B)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on day 22. …”
-
6
-
7
-
8
Charts revealing A) the significant decrease (<i>p</i> < 0.05) in the membrane integrity and B) the significant increase (<i>p</i> < 0.05) in the membrane permeability after treatment with harmalacidine hydrochloride in a representative <i>S. aureus</i> isolate (n = 3 as technical repeats of the same isolate).
Published 2025“…<p>Charts revealing A) the significant decrease (<i>p</i> < 0.05) in the membrane integrity and B) the significant increase (<i>p</i> < 0.05) in the membrane permeability after treatment with harmalacidine hydrochloride in a representative <i>S. aureus</i> isolate (n = 3 as technical repeats of the same isolate).…”
-
9
-
10
HFD decreases ITM and alters metabolic homeostasis.
Published 2025“…Two-way ANOVA, n.s., not significant, ** p < 0.01). <b>(F)</b> Long-term memory (LTM) was significantly decreased in the HFD group. …”
-
11
-
12
-
13
ABT199 inhibits ALK <sup>mutant</sup> kinase activity and decreases it phosphorylation.
Published 2025Subjects: -
14
The influence of fluoxetine treatment on <i>P</i>. <i>berghei</i> pathogenesis.
Published 2024Subjects: -
15
-
16
Subgroup Meta Analysis for HE Incidence Based on Treatment Duration and Dose.
Published 2025Subjects: -
17
-
18
-
19
-
20